<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02726451</url>
  </required_header>
  <id_info>
    <org_study_id>PCA-SD-01</org_study_id>
    <nct_id>NCT02726451</nct_id>
  </id_info>
  <brief_title>A Study to Examine the Effects of Cosmeceutical Therapy in Subjects Undergoing Full Facial Rejuvenation</brief_title>
  <official_title>A Post-Market, Randomized, Placebo-Controlled Study to Assess the Efficacy of Cosmeceutical Therapy in Subjects Undergoing Full Facial Rejuvenation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>DeNova Research</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>DeNova Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to determine the efficacy of Sensi Peel®, Rejuvenating&#xD;
      Serum, and the C&amp;E Strength Max skin care products in subjects who undergo full facial&#xD;
      rejuvenation, with a botulinum neurotoxin A and/or hyaluronic acid filler, in improving the&#xD;
      appearance of the skin, patient satisfaction with aesthetic appearance, and the projected&#xD;
      first impressions.&#xD;
&#xD;
      The secondary objective of this study is to examine patient satisfaction with the continuous&#xD;
      use of Sensi Peel®, Rejuvenating Serum, and the C&amp;E Strength Max products.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Actual">December 11, 2016</completion_date>
  <primary_completion_date type="Actual">November 7, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>C-GAIS by the PI or Designee</measure>
    <time_frame>Approximately 3 months from the baseline visit</time_frame>
    <description>Global aesthetic improvement in subjects is assessed by the PI/designee using the Global Aesthetic Improvement Scale (C-GAIS).&#xD;
Clinical-Global Aesthetic Improvement Scale (C-GAIS):&#xD;
3 (Very Much Improved) 2 (Much Improved)&#xD;
1 (Improved) 0 (No change)&#xD;
-1 (Worse)&#xD;
Scores closer to 3 show a more favorable outcome Scores closer to -1 show a less favorable outcome</description>
  </primary_outcome>
  <primary_outcome>
    <measure>SQA by the PI or Designee</measure>
    <time_frame>Approximately 3 months from the baseline visit</time_frame>
    <description>The quality of subjects' skin is assessed by PI/designee using the Skin Quality Assessment (SQA)&#xD;
Skin Quality Assessment (SQA):&#xD;
Tone (dyschromia) 0 - severe unevenness&#xD;
1- moderate to severe unevenness 2 - moderate unevenness 3 - mild unevenness 4 - even&#xD;
Elasticity (Firmness) 0 - Very poor elasticity&#xD;
- poor elasticity&#xD;
- fair elasticity&#xD;
- good elasticity&#xD;
- firm&#xD;
Texture (Smoothness) 0 - severe&#xD;
- moderate to severe&#xD;
- moderate&#xD;
- mild&#xD;
- none&#xD;
Radiance 0 - severe dullness&#xD;
- moderate to severe dullness&#xD;
- moderate dullness&#xD;
- mild dullness&#xD;
- radiant&#xD;
All scores with a higher number indicate favorable results All scores with a lower number indicate less favorable results</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Face-Q by Subjects</measure>
    <time_frame>Final assessment is approximately 3 months from the baseline visit</time_frame>
    <description>Subjects self-evaluation of their quality of skin, age-appraisal, and social and psychological assessments are performed using the Face-Q questionnaire.&#xD;
FACE-Q (Satisfaction with Skin): scored between 1-4 for 12 questions. Total score closer to 48 indicates a more favorable outcome FACE-Q (Satisfaction with Facial Appearance Overall): scored between 1-4 for 10 questions. Total score closer to 40 indicates a more favorable outcome FACE-Q (Aging Appearance Appraisal): scored between 1-4 for 7 questions. Total score closer to 28 indicates a more favorable outcome FACE-Q (Age Appraisal-VAS): scored between -15 to +15. Total score closer to -15 indicates a more favorable outcome FACE-Q (Psychological Well-Being): scored between 1-4 for 10 questions. Total score closer to 40 indicates a more favorable outcome FACE-Q (Social Function):scored between 1-4 for 8 questions. Total score closer to 32 indicates a more favorable outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SSES by Subjects</measure>
    <time_frame>Final assessment is approximately 3 months from the baseline visit</time_frame>
    <description>Changes in self-esteem is assessed using the State Self-Esteem Scale (SSES): performance, social, and appearance&#xD;
State Self-Esteem Scale (SSES): scored between 1-5 for 20 questions. Scores closer to 100 indicate a more favorable outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>FIQ by Blinded Evaluators</measure>
    <time_frame>At the conclusion of study assessments (approximately 3 months from the baseline visit)</time_frame>
    <description>The projected first impressions are assessed by blinded evaluators using the First Impression Questionnaire (FIQ).&#xD;
First Impression Questionnaire (FIQ): scored between 1-10 for 8 questions. Scores closer to 10 for each question indicate a more favorable outcome</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Facial Rejuvenation With Neurotoxins and/or Hyaluronic Acid Fillers</condition>
  <arm_group>
    <arm_group_label>Basic Skin Care</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Subjects use a basic skin care regimen.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Active Skin Care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects use the Sensi Peel®, Rejuvenating Serum, and C&amp;E Strength Max skin care products in additional to a basic skin care regiment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Basic Skin Care</intervention_name>
    <description>Facial Wash, Hydrator Plus Broad Spectrum SPF 30, and Rebalance skin care products (PCA SKIN®)</description>
    <arm_group_label>Basic Skin Care</arm_group_label>
    <other_name>Group A</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Active Skin Care</intervention_name>
    <description>Sensi Peel®, Rejuvenating Serum, and C&amp;E Strength Max skin care products (PCA SKIN®) in addition to the Facial Wash, Hydrator Plus Broad Spectrum SPF 30, and Rebalance skin care products (PCA SKIN®)</description>
    <arm_group_label>Active Skin Care</arm_group_label>
    <other_name>Group B</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subject is a female between the ages of 21 and 60;&#xD;
&#xD;
          -  Subject requires a full facial rejuvenation with a HA soft tissue filler and/or&#xD;
             botulinum neurotoxin, per judgment of the PI or designee;&#xD;
&#xD;
          -  Subject is willing and able to provide written informed consent prior to the&#xD;
             performance of any study related procedure;&#xD;
&#xD;
          -  Subject is willing and able to comply with the protocol requirements; and&#xD;
&#xD;
          -  Subject is willing and able to provide written photo consent and adhere to the&#xD;
             photography and video procedures such as removal of jewelry and makeup.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subjects who have received any facial filler in the 12-month or neurotoxin treatments&#xD;
             in the 4-month period prior to enrollment;&#xD;
&#xD;
          -  Previous treatment with any resurfacing facial aesthetic procedure (e.g. deep chemical&#xD;
             peeling and laser treatments) within the 12-month period prior to enrollment;&#xD;
&#xD;
          -  Previous treatment with photo rejuvenation therapy within the 6-month period prior to&#xD;
             enrollment;&#xD;
&#xD;
          -  Subjects who plan to undergo facial cosmetic surgery or any aesthetic procedure (e.g.&#xD;
             neurotoxins, dermal fillers, laser treatments, and chemical peels), which are not&#xD;
             specified in this protocol, during the course of the study;&#xD;
&#xD;
          -  A known allergy or sensitivity to any component of the study ingredients;&#xD;
&#xD;
          -  Use of systemic steroids or anticoagulation medications;&#xD;
&#xD;
          -  Subjects with a history of bleeding disorders;&#xD;
&#xD;
          -  Subjects with severe allergies manifested by a history of anaphylaxis or presence of&#xD;
             multiple severe allergies;&#xD;
&#xD;
          -  Subjects with hypersensitivity to botulinum neurotoxin;&#xD;
&#xD;
          -  Subject with allergies to gram positive bacterial proteins;&#xD;
&#xD;
          -  Sensitivity to sulfides;&#xD;
&#xD;
          -  Subjects with allergy to cow's milk protein;&#xD;
&#xD;
          -  Subjects with previous history of sensitivity to amide type local anesthetics;&#xD;
&#xD;
          -  Subject with surgical alterations to the facial anatomy or marked facial asymmetry;&#xD;
&#xD;
          -  Inflammation or infection at the injection site(s);&#xD;
&#xD;
          -  Subjects with a history of eyelid or eyebrow ptosis;&#xD;
&#xD;
          -  Excessive dermatochalasis, deep dermal scarring, or thick sebaceous skin;&#xD;
&#xD;
          -  Subjects with neuromuscular disorders;&#xD;
&#xD;
          -  Use of anticholinergic, aminoglycosides or other agents that interfere with&#xD;
             neuromuscular transmission (e.g., curare-like agents), or muscle relaxants;&#xD;
&#xD;
          -  Subjects with immunodeficiencies such as HIV, lupus, scleroderma, and systemic&#xD;
             infections;&#xD;
&#xD;
          -  Pregnant, nursing, or sexually active female subjects who are of childbearing&#xD;
             potential and who are not willing to use an acceptable form of contraception (e.g.,&#xD;
             barrier methods used with a spermicidal agent, hormonal methods, IUD, surgical&#xD;
             sterilization, abstinence);&#xD;
&#xD;
          -  Current history of chronic drug or alcohol abuse;&#xD;
&#xD;
          -  Concurrent therapy that, in the investigator's opinion, would interfere with the&#xD;
             evaluation of the safety or efficacy of the study product;&#xD;
&#xD;
          -  Subjects who, in the investigator's opinion, have a history of poor cooperation,&#xD;
             non-compliance with medical treatment, or unreliability; and&#xD;
&#xD;
          -  Enrollment in any active study involving the use of investigational devices or drugs.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steven H Dayan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>DeNova Research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>DeNova Research</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>March 29, 2016</study_first_submitted>
  <study_first_submitted_qc>March 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 1, 2016</study_first_posted>
  <results_first_submitted>August 11, 2020</results_first_submitted>
  <results_first_submitted_qc>September 18, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">October 14, 2020</results_first_posted>
  <last_update_submitted>September 18, 2020</last_update_submitted>
  <last_update_submitted_qc>September 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Facies</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Basic Skin Care</title>
          <description>Subjects use a basic skin care regimen.&#xD;
Basic Skin Care: Facial Wash, Hydrator Plus Broad Spectrum SPF 30, and Rebalance skin care products (PCA SKIN®)</description>
        </group>
        <group group_id="P2">
          <title>Active Skin Care</title>
          <description>Subjects use the Sensi Peel®, Rejuvenating Serum, and C&amp;E Strength Max skin care products in additional to a basic skin care regiment.&#xD;
Active Skin Care: Sensi Peel®, Rejuvenating Serum, and C&amp;E Strength Max skin care products (PCA SKIN®) in addition to the Facial Wash, Hydrator Plus Broad Spectrum SPF 30, and Rebalance skin care products (PCA SKIN®)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Basic Skin Care</title>
          <description>Subjects use a basic skin care regimen.&#xD;
Basic Skin Care: Facial Wash, Hydrator Plus Broad Spectrum SPF 30, and Rebalance skin care products (PCA SKIN®)</description>
        </group>
        <group group_id="B2">
          <title>Active Skin Care</title>
          <description>Subjects use the Sensi Peel®, Rejuvenating Serum, and C&amp;E Strength Max skin care products in additional to a basic skin care regiment.&#xD;
Active Skin Care: Sensi Peel®, Rejuvenating Serum, and C&amp;E Strength Max skin care products (PCA SKIN®) in addition to the Facial Wash, Hydrator Plus Broad Spectrum SPF 30, and Rebalance skin care products (PCA SKIN®)</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
            <count group_id="B2" value="10"/>
            <count group_id="B3" value="20"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="54.3" lower_limit="41" upper_limit="68"/>
                    <measurement group_id="B2" value="54.3" lower_limit="41" upper_limit="68"/>
                    <measurement group_id="B3" value="54.3" lower_limit="41" upper_limit="68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>C-GAIS by the PI or Designee</title>
        <description>Global aesthetic improvement in subjects is assessed by the PI/designee using the Global Aesthetic Improvement Scale (C-GAIS).&#xD;
Clinical-Global Aesthetic Improvement Scale (C-GAIS):&#xD;
3 (Very Much Improved) 2 (Much Improved)&#xD;
1 (Improved) 0 (No change)&#xD;
-1 (Worse)&#xD;
Scores closer to 3 show a more favorable outcome Scores closer to -1 show a less favorable outcome</description>
        <time_frame>Approximately 3 months from the baseline visit</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Basic Skin Care</title>
            <description>Subjects use a basic skin care regimen.&#xD;
Basic Skin Care: Facial Wash, Hydrator Plus Broad Spectrum SPF 30, and Rebalance skin care products (PCA SKIN®)</description>
          </group>
          <group group_id="O2">
            <title>Active Skin Care</title>
            <description>Subjects use the Sensi Peel®, Rejuvenating Serum, and C&amp;E Strength Max skin care products in additional to a basic skin care regiment.&#xD;
Active Skin Care: Sensi Peel®, Rejuvenating Serum, and C&amp;E Strength Max skin care products (PCA SKIN®) in addition to the Facial Wash, Hydrator Plus Broad Spectrum SPF 30, and Rebalance skin care products (PCA SKIN®)</description>
          </group>
        </group_list>
        <measure>
          <title>C-GAIS by the PI or Designee</title>
          <description>Global aesthetic improvement in subjects is assessed by the PI/designee using the Global Aesthetic Improvement Scale (C-GAIS).&#xD;
Clinical-Global Aesthetic Improvement Scale (C-GAIS):&#xD;
3 (Very Much Improved) 2 (Much Improved)&#xD;
1 (Improved) 0 (No change)&#xD;
-1 (Worse)&#xD;
Scores closer to 3 show a more favorable outcome Scores closer to -1 show a less favorable outcome</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Visit 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.22" spread="0.441"/>
                    <measurement group_id="O2" value="2.13" spread="0.835"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 8/9</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.75" spread="0.886"/>
                    <measurement group_id="O2" value="2.75" spread="0.787"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>SQA by the PI or Designee</title>
        <description>The quality of subjects' skin is assessed by PI/designee using the Skin Quality Assessment (SQA)&#xD;
Skin Quality Assessment (SQA):&#xD;
Tone (dyschromia) 0 - severe unevenness&#xD;
1- moderate to severe unevenness 2 - moderate unevenness 3 - mild unevenness 4 - even&#xD;
Elasticity (Firmness) 0 - Very poor elasticity&#xD;
- poor elasticity&#xD;
- fair elasticity&#xD;
- good elasticity&#xD;
- firm&#xD;
Texture (Smoothness) 0 - severe&#xD;
- moderate to severe&#xD;
- moderate&#xD;
- mild&#xD;
- none&#xD;
Radiance 0 - severe dullness&#xD;
- moderate to severe dullness&#xD;
- moderate dullness&#xD;
- mild dullness&#xD;
- radiant&#xD;
All scores with a higher number indicate favorable results All scores with a lower number indicate less favorable results</description>
        <time_frame>Approximately 3 months from the baseline visit</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Basic Skin Care</title>
            <description>Subjects use a basic skin care regimen.&#xD;
Basic Skin Care: Facial Wash, Hydrator Plus Broad Spectrum SPF 30, and Rebalance skin care products (PCA SKIN®)</description>
          </group>
          <group group_id="O2">
            <title>Active Skin Care</title>
            <description>Subjects use the Sensi Peel®, Rejuvenating Serum, and C&amp;E Strength Max skin care products in additional to a basic skin care regiment.&#xD;
Active Skin Care: Sensi Peel®, Rejuvenating Serum, and C&amp;E Strength Max skin care products (PCA SKIN®) in addition to the Facial Wash, Hydrator Plus Broad Spectrum SPF 30, and Rebalance skin care products (PCA SKIN®)</description>
          </group>
        </group_list>
        <measure>
          <title>SQA by the PI or Designee</title>
          <description>The quality of subjects' skin is assessed by PI/designee using the Skin Quality Assessment (SQA)&#xD;
Skin Quality Assessment (SQA):&#xD;
Tone (dyschromia) 0 - severe unevenness&#xD;
1- moderate to severe unevenness 2 - moderate unevenness 3 - mild unevenness 4 - even&#xD;
Elasticity (Firmness) 0 - Very poor elasticity&#xD;
- poor elasticity&#xD;
- fair elasticity&#xD;
- good elasticity&#xD;
- firm&#xD;
Texture (Smoothness) 0 - severe&#xD;
- moderate to severe&#xD;
- moderate&#xD;
- mild&#xD;
- none&#xD;
Radiance 0 - severe dullness&#xD;
- moderate to severe dullness&#xD;
- moderate dullness&#xD;
- mild dullness&#xD;
- radiant&#xD;
All scores with a higher number indicate favorable results All scores with a lower number indicate less favorable results</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Tone - Visit 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.44" spread="0.527"/>
                    <measurement group_id="O2" value="1.20" spread="0.422"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tone - Visit 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.78" spread="0.667"/>
                    <measurement group_id="O2" value="2.75" spread="0.707"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tone - Visit 8/9</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.88" spread="0.641"/>
                    <measurement group_id="O2" value="3.14" spread="0.690"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Elasticity - Visit 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.33" spread="0.5"/>
                    <measurement group_id="O2" value="1.30" spread="0.483"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Elasticity - Visit 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.33" spread="0.5"/>
                    <measurement group_id="O2" value="3.25" spread="0.886"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Elasticity - Visit 8/9</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.75" spread="0.707"/>
                    <measurement group_id="O2" value="3.57" spread="0.535"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Texture - Visit 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.11" spread="0.601"/>
                    <measurement group_id="O2" value="1.10" spread="0.316"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Texture - Visit 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.33" spread="0.5"/>
                    <measurement group_id="O2" value="3.25" spread="0.886"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Texture - Visit 8/9</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.88" spread="0.835"/>
                    <measurement group_id="O2" value="3.71" spread="0.488"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Radiance - Visit 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.88" spread="0.354"/>
                    <measurement group_id="O2" value="1.0" spread=".0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Radiance - Visit 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.25" spread="0.707"/>
                    <measurement group_id="O2" value="3.25" spread="0.886"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Radiance - Visit 8/9</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.00" spread="0.926"/>
                    <measurement group_id="O2" value="3.71" spread="0.488"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Face-Q by Subjects</title>
        <description>Subjects self-evaluation of their quality of skin, age-appraisal, and social and psychological assessments are performed using the Face-Q questionnaire.&#xD;
FACE-Q (Satisfaction with Skin): scored between 1-4 for 12 questions. Total score closer to 48 indicates a more favorable outcome FACE-Q (Satisfaction with Facial Appearance Overall): scored between 1-4 for 10 questions. Total score closer to 40 indicates a more favorable outcome FACE-Q (Aging Appearance Appraisal): scored between 1-4 for 7 questions. Total score closer to 28 indicates a more favorable outcome FACE-Q (Age Appraisal-VAS): scored between -15 to +15. Total score closer to -15 indicates a more favorable outcome FACE-Q (Psychological Well-Being): scored between 1-4 for 10 questions. Total score closer to 40 indicates a more favorable outcome FACE-Q (Social Function):scored between 1-4 for 8 questions. Total score closer to 32 indicates a more favorable outcome</description>
        <time_frame>Final assessment is approximately 3 months from the baseline visit</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Basic Skin Care</title>
            <description>Subjects use a basic skin care regimen.&#xD;
Basic Skin Care: Facial Wash, Hydrator Plus Broad Spectrum SPF 30, and Rebalance skin care products (PCA SKIN®)</description>
          </group>
          <group group_id="O2">
            <title>Active Skin Care</title>
            <description>Subjects use the Sensi Peel®, Rejuvenating Serum, and C&amp;E Strength Max skin care products in additional to a basic skin care regiment.&#xD;
Active Skin Care: Sensi Peel®, Rejuvenating Serum, and C&amp;E Strength Max skin care products (PCA SKIN®) in addition to the Facial Wash, Hydrator Plus Broad Spectrum SPF 30, and Rebalance skin care products (PCA SKIN®)</description>
          </group>
        </group_list>
        <measure>
          <title>Face-Q by Subjects</title>
          <description>Subjects self-evaluation of their quality of skin, age-appraisal, and social and psychological assessments are performed using the Face-Q questionnaire.&#xD;
FACE-Q (Satisfaction with Skin): scored between 1-4 for 12 questions. Total score closer to 48 indicates a more favorable outcome FACE-Q (Satisfaction with Facial Appearance Overall): scored between 1-4 for 10 questions. Total score closer to 40 indicates a more favorable outcome FACE-Q (Aging Appearance Appraisal): scored between 1-4 for 7 questions. Total score closer to 28 indicates a more favorable outcome FACE-Q (Age Appraisal-VAS): scored between -15 to +15. Total score closer to -15 indicates a more favorable outcome FACE-Q (Psychological Well-Being): scored between 1-4 for 10 questions. Total score closer to 40 indicates a more favorable outcome FACE-Q (Social Function):scored between 1-4 for 8 questions. Total score closer to 32 indicates a more favorable outcome</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Satisfaction with Skin - V5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.21" spread="0.88"/>
                    <measurement group_id="O2" value="3.54" spread="0.778"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with Skin - V7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.27" spread="0.667"/>
                    <measurement group_id="O2" value="3.29" spread="0.787"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with Skin - V8/9</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.6" spread="0.641"/>
                    <measurement group_id="O2" value="3.18" spread="0.690"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with Facial Appearance Overall - V5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.14" spread="0.5"/>
                    <measurement group_id="O2" value="3.13" spread="0.483"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with Facial Appearance Overall - V7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.08" spread="0.5"/>
                    <measurement group_id="O2" value="3.06" spread="0.886"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with Facial Appearance Overall - V8/9</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.46" spread="0.707"/>
                    <measurement group_id="O2" value="3.1" spread="0.535"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Aging Appearance Appraisal - V5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.22" spread="0.601"/>
                    <measurement group_id="O2" value="1.79" spread="0.316"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Aging Appearance Appraisal - V7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.08" spread="0.5"/>
                    <measurement group_id="O2" value="1.88" spread="0.886"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Aging Appearance Appraisal - V8/9</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.45" spread="0.835"/>
                    <measurement group_id="O2" value="1.61" spread="0.488"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Age Appraisal-VAS - V5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2" spread="0.354"/>
                    <measurement group_id="O2" value="-3" spread="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Age Appraisal-VAS - V7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.22" spread="0.707"/>
                    <measurement group_id="O2" value="-3.13" spread="0.886"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Age Appraisal-VAS - V8/9</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.38" spread="0.926"/>
                    <measurement group_id="O2" value="-3.57" spread="0.488"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Psychological Well-Being - V5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.5" spread="0.568"/>
                    <measurement group_id="O2" value="3.54" spread="0.526"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Psychological Well-Being - V7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.52" spread="0.552"/>
                    <measurement group_id="O2" value="3.66" spread="0.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Psychological Well-Being - V8/9</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.81" spread="0.699"/>
                    <measurement group_id="O2" value="3.8" spread="0.658"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Social Function - V5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.51" spread="0.553"/>
                    <measurement group_id="O2" value="3.53" spread="0.633"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Social Function - V7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.56" spread="0.878"/>
                    <measurement group_id="O2" value="3.58" spread="0.925"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Social Function - V8/9</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.67" spread="0.787"/>
                    <measurement group_id="O2" value="3.57" spread="0.477"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>SSES by Subjects</title>
        <description>Changes in self-esteem is assessed using the State Self-Esteem Scale (SSES): performance, social, and appearance&#xD;
State Self-Esteem Scale (SSES): scored between 1-5 for 20 questions. Scores closer to 100 indicate a more favorable outcome</description>
        <time_frame>Final assessment is approximately 3 months from the baseline visit</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Basic Skin Care</title>
            <description>Subjects use a basic skin care regimen.&#xD;
Basic Skin Care: Facial Wash, Hydrator Plus Broad Spectrum SPF 30, and Rebalance skin care products (PCA SKIN®)</description>
          </group>
          <group group_id="O2">
            <title>Active Skin Care</title>
            <description>Subjects use the Sensi Peel®, Rejuvenating Serum, and C&amp;E Strength Max skin care products in additional to a basic skin care regiment.&#xD;
Active Skin Care: Sensi Peel®, Rejuvenating Serum, and C&amp;E Strength Max skin care products (PCA SKIN®) in addition to the Facial Wash, Hydrator Plus Broad Spectrum SPF 30, and Rebalance skin care products (PCA SKIN®)</description>
          </group>
        </group_list>
        <measure>
          <title>SSES by Subjects</title>
          <description>Changes in self-esteem is assessed using the State Self-Esteem Scale (SSES): performance, social, and appearance&#xD;
State Self-Esteem Scale (SSES): scored between 1-5 for 20 questions. Scores closer to 100 indicate a more favorable outcome</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80.5" spread="0.527"/>
                    <measurement group_id="O2" value="78.5" spread="0.422"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79" spread="0.886"/>
                    <measurement group_id="O2" value="80" spread="0.707"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 8/9</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84" spread="0.641"/>
                    <measurement group_id="O2" value="85" spread="0.690"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>FIQ by Blinded Evaluators</title>
        <description>The projected first impressions are assessed by blinded evaluators using the First Impression Questionnaire (FIQ).&#xD;
First Impression Questionnaire (FIQ): scored between 1-10 for 8 questions. Scores closer to 10 for each question indicate a more favorable outcome</description>
        <time_frame>At the conclusion of study assessments (approximately 3 months from the baseline visit)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Basic Skin Care</title>
            <description>Subjects use a basic skin care regimen.&#xD;
Basic Skin Care: Facial Wash, Hydrator Plus Broad Spectrum SPF 30, and Rebalance skin care products (PCA SKIN®)</description>
          </group>
          <group group_id="O2">
            <title>Active Skin Care</title>
            <description>Subjects use the Sensi Peel®, Rejuvenating Serum, and C&amp;E Strength Max skin care products in additional to a basic skin care regiment.&#xD;
Active Skin Care: Sensi Peel®, Rejuvenating Serum, and C&amp;E Strength Max skin care products (PCA SKIN®) in addition to the Facial Wash, Hydrator Plus Broad Spectrum SPF 30, and Rebalance skin care products (PCA SKIN®)</description>
          </group>
        </group_list>
        <measure>
          <title>FIQ by Blinded Evaluators</title>
          <description>The projected first impressions are assessed by blinded evaluators using the First Impression Questionnaire (FIQ).&#xD;
First Impression Questionnaire (FIQ): scored between 1-10 for 8 questions. Scores closer to 10 for each question indicate a more favorable outcome</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Social skills - Before</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.9525" spread="0.79094"/>
                    <measurement group_id="O2" value="5.0600" spread="0.83857"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Social skills - After</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.9136" spread="0.64010"/>
                    <measurement group_id="O2" value="6.3333" spread="1.67975"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Academic Performance - Before</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.3400" spread="0.83351"/>
                    <measurement group_id="O2" value="5.3900" spread="0.78095"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Academic Performance - After</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.1550" spread="0.48823"/>
                    <measurement group_id="O2" value="6.2800" spread="1.63815"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dating success - Before</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.6700" spread="1.21824"/>
                    <measurement group_id="O2" value="5.0367" spread="0.99995"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dating success - After</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.5470" spread="0.85017"/>
                    <measurement group_id="O2" value="6.1433" spread="1.85263"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Occupational success - Before</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.3350" spread="0.93159"/>
                    <measurement group_id="O2" value="5.5233" spread="0.77835"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Occupational success - After</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.0723" spread="0.57428"/>
                    <measurement group_id="O2" value="6.3967" spread="1.58576"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Attractiveness - Before</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.7225" spread="1.27725"/>
                    <measurement group_id="O2" value="4.9467" spread="1.07574"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Attractiveness - After</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.7758" spread="1.03805"/>
                    <measurement group_id="O2" value="6.0867" spread="1.95090"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Financial Success - Before</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.3025" spread="0.92139"/>
                    <measurement group_id="O2" value="5.3567" spread="0.81363"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Financial Success - After</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.0309" spread="0.61463"/>
                    <measurement group_id="O2" value="6.2467" spread="1.58249"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Relationship success - Before</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.0850" spread="0.96094"/>
                    <measurement group_id="O2" value="5.2167" spread="0.76078"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Relationship success - After</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.9597" spread="0.69371"/>
                    <measurement group_id="O2" value="6.3233" spread="1.70127"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Athletic success - Before</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.6475" spread="1.31627"/>
                    <measurement group_id="O2" value="4.6767" spread="1.03115"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Athletic success - After</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.4897" spread="0.96880"/>
                    <measurement group_id="O2" value="5.7467" spread="1.67741"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Basic Skin Care</title>
          <description>Subjects use a basic skin care regimen.&#xD;
Basic Skin Care: Facial Wash, Hydrator Plus Broad Spectrum SPF 30, and Rebalance skin care products (PCA SKIN®)</description>
        </group>
        <group group_id="E2">
          <title>Active Skin Care</title>
          <description>Subjects use the Sensi Peel®, Rejuvenating Serum, and C&amp;E Strength Max skin care products in additional to a basic skin care regiment.&#xD;
Active Skin Care: Sensi Peel®, Rejuvenating Serum, and C&amp;E Strength Max skin care products (PCA SKIN®) in addition to the Facial Wash, Hydrator Plus Broad Spectrum SPF 30, and Rebalance skin care products (PCA SKIN®)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Steven Dayan, MD</name_or_title>
      <organization>DeNova Research</organization>
      <phone>3123352070</phone>
      <email>sdayan@drdayan.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

